Uganda Pharmaceutical Sector Baseline Survey: ANNEXES: Survey form 8: Public Health Facility - Standard Treatment Guidelines/EDL

Home page | Help | Clear

English | French

Search | Categories | Titles A-Z | Countries | Compare countries | Index

Expand Document

Printable HTML version

Export document as HTML file Help

Abbreviations


	Uganda Pharmaceutical Sector Baseline Survey (HAI, WHO; 2002; 67 pages)
		Foreword
		Acknowledgments
		Abbreviations
		Executive summary
		1. Introduction
			a) Demographic characteristics
			b) Health characteristics
			c) Health policy
			d) Health system structure
			e) The Pharmaceutical Sector
				i) National Drug Policy
				ii) Drug supply system
				iii) Key pharmaceutical indicators
				iv) Pharmaceutical sector surveys
		2. Study Design and Methodology
			2.1 Objectives of the survey
			2.2 Methodology
				a) Level I indicators
				b) List of Level II indicators
				c) List of household survey indicators
				d) Training and Sampling
				e) The survey
				f) Ethical Considerations
		3. Findings
			3.1 Level I: Structures and processes of country pharmaceutical situation
			3.2 Level II: Core indicator results
				a) Summary of the Level II core indicator results
				b) Accessibility to Drugs
				c) Stock-out duration in public health facilities and district warehouses
				d) Percentage of prescribed drugs actually dispensed to patients in public health facilities
				e) Affordability of key drugs in public health facilities and private dispensing drug outlets
				f) Prices of key drugs in public health facilities and private dispensing drug outlets
				g) Quality of drugs
				h) Rational drug use
					i) Number of drugs prescribed per patient contact at public health facilities
					ii) Percentage of patients receiving an antibiotic at public health facilities
					iii) Percentage of patients receiving an injection at public health facilities
					iv) Percentage of prescribed drugs on EDLU in public health facilities
					v) Adequacy of labelling at public health facilities
					vi) Adequacy of patient knowledge of how to take medicines at public health facilities
					vii) Prescribing according to STGs at public health facilities
					viii) Availability of STGs and EDLU at public health facilities
			3.3 Household survey results
		4. Interpretation of Results
		5. Conclusions and Recommendations
			a) Conclusions: Positive aspects and areas for improvement identified
			b) Recommendations Summary
		ANNEXES
			Annex 1: Questionnaire on structures and processes of country pharmaceutical situation (Level I)
			Annex 2: Results of Previous Pharmaceutical Sector Surveys
			Annex 3: Adaptation of survey forms with country specific information for Uganda
			Annex 4: Survey forms
			Survey form 1a: Central/District Warehouse
			Survey form 2a: Central/District Warehouse
			Survey form 3a: Central/District Warehouse: Storage Checklist
			Survey form 1b: Public Health Facility
			Survey form 2b: Public Health Facility
			Survey form 3b: Public Health Facility Storage Checklist
			Survey form 4a: Public Health Facility Pharmacy
			Survey form 4b: Private Pharmacy
			Survey form 5: Private Pharmacy
			Survey form 6: Public Health Facility: Rational Drug Use - Prescribing Indicator Form
			Survey form 7: Public Health Facility Rational Drug Use - Patient Care Form
			Survey form 8: Public Health Facility - Standard Treatment Guidelines/EDL
			Survey form 9: Public Health Facility: Treatment of Diarrhoea, ARI, and Pneumonia
			Survey form 9 (cont.): Public Health Facility: Treatment of Other Tracer Diseases
			Survey form 10: Household

Survey form 8: Public Health Facility - Standard Treatment Guidelines/EDL

Indicator:	Availability of STG for common local conditions
	Availability of Essential Drug List (EDL) at the facility

Public Health Facility
Facility #____ (1-30)

Facility _______________________	Date ________________________
Location ______________________	Investigator __________________

Tick box with correct answer

Standard treatment guidelines available	Yes¹	No
National STG
STG for URTI
STG for Diarrhoea
STG for Pneumonia
STG for Malaria
STG for Tuberculosis
Others:

EDL available	Yes¹	No
National EDL
Provincial/District
Primary EDL
Others:

STG is available in this facility²	Yes¹	No
EDL is available in this facility³	Yes¹	No

Notes
1.	Mark “yes” only if the facility is able to show you the document.
2.	The facility is considered to have an STG if any one of the above STGs is available provided it was developed by an independent group and is not associated with promoting pharmaceutical products.
3.	Before the survey, the most up-to-date version of EDL must be identified. The facility is considered to have an EDL if any one of the above EDLs is available.

Please provide your feedback

Abbreviations

English | French